Expression of Stathmin gene in ovarian cancer tissue and its valuation value on effect of Paclitaxel combined with cisplatin chemotherapy
10.3969/j.issn.1005-1678.2017.07.006
- VernacularTitle:Stathmin基因在卵巢癌组织中的表达及其对紫杉醇联合顺铂化疗效果的评估价值
- Author:
Chaojun WANG
;
Li LI
;
Huajing ZHANG
;
Pengfei DOU
;
Tengzhou ZHANG
;
Guanhua CHE
- Keywords:
ovarian cancer;
Stathmin gene;
chemotherapy;
tumor marker;
angiogenesis
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(7):20-22
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the expression of Stathmin gene in ovarian cancer tissue and its valuation value on effect of Paclitaxel combined with cisplatin chemotherapy.Methods 92 cases of ovarian cancerpatients underwent surgical and postoperative chemotherapy treatment in our hospital during July 2012 to February 2016 were selected with research subject.The expression of Stathmin gene in ovarian cancer tissues and adjacent tissues was measured by fluorescence quantitative PCR.All ovarian cancer patients were divided into high Stathmin group and low Stathmin group with 46 cases according to the expression of Stathmin gene in ovarian cancer tissues.Comparison the chemotherapy effectin ovarian cancerpatients with different Stathmin gene expression.Results The expression of Stathmin mRNA in ovarian cancer tissues was significantly higher than that in adjacent tissues(P<0.05).After chemotherapy, serum tumor markers such as HE4, CA199, CA153, β-HCG in high Stathmin group were higher than those in low Stathmin group, angiogenesis indexes such as CXCR4, SDF-1, VEGF, Ang2 were lower than those in low Stathmin group, apoptotic indexes such as Fas/Apo-1 and Bcl-2 were higher than those in low Stathmin group(P<0.05).Conclusion Stathmin gene is highly expressed in ovarian cancer tissues, and the expression of Stathmin is negatively correlated with chemotherapy.
